Sinovac Biotech (SVA) Non-Current Assets (2009 - 2026)
Sinovac Biotech (SVA) recorded Non-Current Assets of $1.51 billion in Q2 2026, down 6.0% from $1.61 billion a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech reported Non-Current Assets of $1.48 billion, down 12.7% from FY2024.
- Annual Non-Current Assets has declined for three straight years, though with a five-year compound annual growth rate of 34.1% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $1.69 billion in FY2024 (-16.0%), $2.01 billion in FY2023 (-26.1%), $2.73 billion in FY2022 (+49.7%) and $1.82 billion in FY2021 (+433.9%).
- Quarterly Non-Current Assets has ranged from $1.48 billion in Q4 2025 to $2.73 billion in Q4 2022 over the past five years.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 433.9% in Q4 2021, against a decline of 26.1% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 1.51 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Bn |
| Dec 31, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.61 Bn |
| Dec 31, 2024 | 1.69 Bn |
| Jun 30, 2024 | 1.75 Bn |
| Dec 31, 2023 | 2.01 Bn |
| Jun 30, 2023 | 1.96 Bn |
| Dec 31, 2022 | 2.73 Bn |
| Jun 30, 2022 | 1.95 Bn |
| Dec 31, 2021 | 1.82 Bn |
| Jun 30, 2021 | 938.80 Mn |
| Dec 31, 2020 | 341.03 Mn |
| Sep 30, 2020 | 233.78 Mn |
| Jun 30, 2020 | 191.36 Mn |
| Mar 31, 2020 | 103.97 Mn |
| Dec 31, 2019 | 102.69 Mn |
| Sep 30, 2019 | 97.29 Mn |
| Jun 30, 2019 | 100.04 Mn |
| Mar 31, 2019 | 98.63 Mn |
| Dec 31, 2018 | 85.61 Mn |
API Access
Sinovac Biotech Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();